Skip to main content

What is change control ? Step by step handling of change control with examples ( Production department)

 In pharmaceutical production, change control is a crucial process that ensures any modifications to equipment, processes, or procedures are managed systematically and safely. Here are some examples of how change control is handled in the pharma industry:


Equipment Change: When a pharmaceutical company decides to replace or upgrade a critical manufacturing equipment, a formal change control process is initiated. It involves assessing the impact of the change, conducting risk assessments, and ensuring proper validation of the new equipment before implementation.


Process Change: If there is a need to modify a manufacturing process, change control is employed to evaluate the potential impact on product quality, safety, and efficacy. This process includes thorough documentation, testing, and validation to ensure the changes do not compromise product quality.


Raw Material Change: When there is a need to switch or modify a raw material used in drug manufacturing, change control is applied to evaluate the impact on the product's quality attributes and regulatory compliance. Any such change must be approved through a formal change control procedure.


Packaging Change: Pharmaceutical products are often subject to changes in packaging materials or design. Change control is employed to assess the impact on product stability, shelf life, and compatibility with the new packaging.


Change in Manufacturing Site: If a company decides to move production from one site to another, extensive change control measures are implemented to ensure the new facility meets regulatory requirements, maintains product quality, and prevents cross-contamination.


In all these examples, the change control process involves a thorough evaluation of potential risks, proper documentation, and adherence to regulatory guidelines to ensure patient safety and product quality are maintained throughout the changes.



The management of change control in pharmaceutical production involves a series of systematic steps to ensure that any modifications to equipment, processes, or procedures are evaluated, documented, and implemented in a controlled manner. Here are the typical steps in the change control process:


Initiation of Change Control Request: The process begins with the identification of a need for change, which could be due to various reasons such as process improvements, equipment upgrades, or regulatory requirements. The individual or department proposing the change initiates a change control request.


Change Proposal and Impact Assessment: A detailed change proposal is prepared, outlining the reasons for the change, its scope, and the intended benefits. An impact assessment is conducted to evaluate potential risks and impacts on product quality, safety, and regulatory compliance.


Change Control Review Board (CCRB): A Change Control Review Board or Committee, composed of cross-functional representatives, reviews the change proposal and impact assessment. The board ensures that all necessary aspects have been considered and evaluates the overall feasibility of the proposed change.


Approval and Authorization: If the Change Control Review Board approves the change, the proposal is formally authorized. The responsible personnel or department is assigned to implement and oversee the change.


Change Implementation Plan: A comprehensive implementation plan is developed, detailing the steps, resources, and timelines required to execute the change. This plan includes risk mitigation strategies and validation requirements.


Validation and Testing: Depending on the nature of the change, validation studies and testing may be conducted to ensure that the modified process or equipment functions as intended and meets the required quality standards.


Documentation and Records: Throughout the change control process, detailed documentation is maintained, including all change-related activities, decisions, and outcomes. This documentation is critical for regulatory compliance and audits.


Training and Communication: All relevant personnel are trained on the changes to ensure proper understanding and adherence to the new procedures. Effective communication is vital to keep all stakeholders informed during the implementation process.


Verification and Monitoring: After the change has been implemented, the process is monitored to ensure it performs as expected. This includes ongoing data collection and analysis to verify that the intended outcomes are achieved.


Closure and Review: Once the change is successfully implemented and verified, the change control process is formally closed. A post-implementation review is conducted to assess the effectiveness of the change and identify any lessons learned for future improvements.


By following these steps, pharmaceutical companies can effectively manage change control in production, ensuring product quality, safety, and compliance are maintained while facilitating continuous improvement in their operations.

Popular posts from this blog

Disintegration Time for tablets as per IP, BP and USP

Disintegration Time:- Uncoated Tablet NMT 15 min, in water with Disc 37 0 C ± 2 0 C Coated Tablet NMT 30 min, In water with Disc for Film Coated Tab , and NMT 60 min Other than Film coated tablet Enteric Coated Tab Intact for 2 hr in 0.1 N HCl & disintegrate within 1 hr in Mixed 6.8 Phosphate buffer. According to USP 2 hr in Simulated gastric fluid, then in Simulated Intestinal Fluid. Dispersible/Soluble Within 3 min in water at 25 0 C ± 1 0 C ( IP ) & 15 – 25 0 C ( BP ) Orodispersible Within 1 min Effervescent Tab 5 min in 250 ml water at 20 – 30 0 C ( IP ) & 5  min in 200 ml water at 15-25 0 C ( BP ) Buccal & Sublingual Not Applicable but dissolve within 15 – 30 min. DT Apparatus:- Mesh Apperture:- 2mm (#10), Cycles:- 28 – 32 cycles/min, 50 – 60 mm distance from bottom & top, Temp of water 37 0 C ± 2 0 C. If 1 or 2 tabs fail, repeat for 12 tabs. Click to Buy Here

Weight variation limit for tablet and capsule.

Weight Variation Limits:- 1) For Tablets  IP/BP.                           Limit.                          USP 80 mg or less.             10%                     130mg or less  80 mg to 250mg.       7.5%               130mg to 324mg 250mg or more.          5%               More than 324mg 2) For Capsule:- IP Limit Less than 300mg 10% 300mg or More 7.5%

Basics and use of HVAC system in pharma

HVAC is an essential aspect in pharmaceutical industry as factors like temperature, relative humidity and ventilation have a direct impact on the quality of the pharmaceutical product. The designing of the HVAC should be sorted out while design concept of facility is in progress as it is linked to the architectural layouts like air locks, doorways and lobbies. Once the HVAC system is properly designed and installed it not only helps to create the required room pressure differential cascades but also prevents the cross contamination. Basically an HVAC system works by transferring the heat and moisture into and out of the air and controls the level of the air pollutant either by removing them or diluting them to a particular level. TECHNOLOGY OVERVIEW: HVAC system varies according to the size and installation capacity within a facility but the basic components remain almost the same. LAYOUT OF A TYPICAL BASIC HVAC SYSTEM HEATING SYSTEM: The heat source is either a furnace or ...